Core Viewpoint - Zhenghai Biological's stock closed at 23.13 yuan, with a PE ratio of 34.44, marking a new low in 84 days, and a total market capitalization of 4.163 billion yuan [1] Company Summary - Zhenghai Biological specializes in the research, production, and sales of bio-regenerative materials, with key products including oral repair membranes, absorbable dura mater patches, bone repair materials, skin repair membranes, surgical packing sponges, self-etching adhesives, active biological bone, dura mater patches, phosphoric acid etchants, and dental pit and fissure sealants [1] - The company was recognized as one of the top 50 new material leading enterprises in Shandong Province for 2023 [1] Financial Performance - For the first half of 2025, the company reported revenue of 188 million yuan, a year-on-year decrease of 5.14%, and a net profit of 46.4857 million yuan, down 45.97%, with a gross profit margin of 83.92% [1] Industry Summary - The average PE ratio for the medical device industry is 54.32, with a median of 38.11, placing Zhenghai Biological at 69th in the industry ranking [1] - The company's PE ratio is significantly lower than the industry average, indicating potential undervaluation [2]
正海生物收盘上涨1.94%,滚动市盈率34.44倍,总市值41.63亿元